Loading viewer...
conference
Format: PDF conference
Sequana Medical presented at the Jefferies London Healthcare Conference on November 16, 2021, discussing innovations in treating diuretic-resistant fluid overload conditions including liver disease, malignant ascites, and heart failure. The company showcased its alfapump® system, which was undergoing clinical investigation in the US and Europe, and DSR® therapy in pre-clinical development.
conference
21 Pages
conference
46 Pages
The Greenbrier Companies, Inc.
EFTISARC-NEO Trial: Pembrolizumab + Eftilagimod Neoadjuvant STS 2024
conferenceconference
1 Pages
Maria Sklodowska-Curie National Research Institute of Oncology